STOCK ALARM
SA
Menu
Demo
Log In
News
Alerts
Portfolio
Screener
AI Ratings
Chart Cockpit
Chart Studio
Movers
PRV.L
(PRV.L)
PRV.L
Overview
Notebook
Intelligence
Chart
History
Fundmntls
TTM
Earnings
Analysts
News
Financials
Segments
Insiders
Institl.
DCF
Peers
Trailing Twelve Months (TTM) Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
Home
Screener
Alerts
Search
More
Prevail Therapeutics Inc
(PRV.L)
$842.00
—
Chart
Share
Post on X
PRV.L
Prevail Therapeutics Inc
(PRV.L)
NASDAQ
$842.00
—
Chart Studio
Share
PRV.L
Per Share (TTM)
Revenue/Share
$4.39
Net Income/Share
$0.41
Operating CF/Share
$0.51
Free CF/Share
$0.31
Cash/Share
$0.38
Book Value/Share
$3.76
Tangible Book/Share
$1.65
Equity/Share
$3.76
Interest Debt/Share
$0.57
CapEx/Share
$0.20
Dividend/Share
$0.05
Valuation
Market Cap
$388.13M
Enterprise Value
$395.66M
P/E Ratio
21.05
P/S Ratio
1.92
P/OCF Ratio
16.41
P/FCF Ratio
26.72
P/B Ratio
2.24
P/TB Ratio
2.24
EV/Sales
1.95
EV/EBITDA
11.50
Graham Valuation
Graham Number
$5.85
Graham Net-Net
$-0.09
Profitability
Earnings Yield
4.81%
FCF Yield
3.74%
ROE
10.96%
ROIC
9.58%
Return on Tangible Assets
12.89%
Dividend
Dividend Yield
0.55%
Payout Ratio
15.80%
Capital Allocation
CapEx/OCF
38.62%
CapEx/Revenue
4.51%
CapEx/Depreciation
1.02
SBC/Revenue
0.00%
SG&A/Revenue
22.94%
R&D/Revenue
0.00%
Liquidity & Solvency
Debt/Equity
0.14
Debt/Assets
0.10
Debt/Market Cap
0.06
Net Debt/EBITDA
0.22
Current Ratio
1.94
Interest Coverage
19.47x
Income Quality
1.27
Efficiency
Days Sales Outstanding
68 days
Days Payables Outstanding
87 days
Days Inventory
105 days
Receivables Turnover
5.36x
Payables Turnover
4.18x
Inventory Turnover
3.46x
Capital Structure
Tangible Assets
$76.08M
Working Capital
$45.03M
Invested Capital
$194.34M
Intangibles/Assets
40.19%